☆ 4.7 Review

Physiological Diagnostic Criteria for Vascular Failure

HYPERTENSION (2018)

Get Full Text
Add to Collection

Journal

HYPERTENSION
Volume 72, Issue 5, Pages 1060-1071

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/HYPERTENSIONAHA.118.11554

Keywords

-

Categories

Peripheral Vascular Disease

Funding

  1. Fukuda Denshi
  2. Mitsubishi Tanabe Pharma Corporation
  3. Teijin
  4. Boehringer Ingelheim
  5. Merck
  6. Sanofi
  7. AstraZeneca
  8. Kyowa Hakko Kirin
  9. Takeda
  10. Astellas
  11. Daiichi Sankyo
  12. Mochida
  13. Nihon Kohden
  14. Shionogi
  15. Nippon Sigmax
  16. Sanwa Kagaku Kenkyusho
  17. Unex
  18. Kao

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.